SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development by James L Gulley, Leisha A Emens, Patrick Hwu, Carlo B Bifulco, Pamela S Ohashi, Christine Moussion, David Feltquate

Get full text

Geno4ME Study: implementation of whole genome sequencing for population screening in a large healthcare system by Isabelle A. Lucas Beckett, Kate R. Emery, Josiah T. Wagner, Kathleen Jade, Benjamin A. Cosgrove, John Welle, JB Rinaldi, Lindsay Dickey, Kyle Jones, Nick Wagner, Eric M. Shull, Jon Clemens, Kalliopi Trachana, Lance Anderson, Allison Kudla, Brett Smith, Hakon Verespej, Li Chi Yuan, Elizabeth Denne, Erica Ramos, Jennifer C. Lovejoy, Krzysztof Olszewski, Martin G. Reese, Misty J. Reynolds, Mandy M. Miller, Alexa K. Dowdell, Brianna Beck, James M. Scanlan, Mary B. Campbell, Andrew T. Magis, Keri Vartanian, Brian D. Piening, Carlo B. Bifulco, Ora K. Gordon

Get full text

Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols by Deborah Collyar, Christian M Capitini, Gary Kohanbash, Yana G Najjar, Carlo B Bifulco, Barbara Seliger, Holden T Maecker, Elizabeth Garrett-Mayer, Joe Yeong, Leslie Cope, Sacha Gnjatic, Sumit K Subudhi, Michael T Lotze, Saman Maleki Vareki, Alaa Ali, Laura Q M Chow, Tricia R Cottrell, Tullia C Bruno, Denise Goh, Codruta Chiuzan, Janis Taube, Ryan J Sullivan, Kristin G Anderson, Isabella C Glitza Oliva, Wim Vos, Paola Grandi, Susan Halabi, Julie Stein Deutsch, Ivan Diaz-Padilla, Anthony R Cillo, Genia Dubrovsky, Sarah Mullin, Elizabeth G Hill, Brian P Hobbs, Phyllis Pettit Nassi, Virgil H Simons, Chris H Takimoto

Get full text